1992
DOI: 10.1016/0378-4347(92)80450-5
|View full text |Cite
|
Sign up to set email alerts
|

Analytical and semi-preparative high-performance liquid chromatographic separation and assay of hydroxychloroquine enantiomers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
22
0
5

Year Published

1993
1993
2024
2024

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 48 publications
(27 citation statements)
references
References 15 publications
0
22
0
5
Order By: Relevance
“…enantiomers (see Fig. 1) (Witiak et al 1981;Craig et al 1988;Titus 1989;Brocks et al 1992;Brocks and Mehvar 2003) with variable stereo-selective elimination (Iredale et al 1993;McLachlan et al 1993McLachlan et al , 1994Tett et al 1994;Ducharme et al 1995;Midha et al 1998;Munster et al 2002;Brocks and Mehvar 2003;de Oliveira et al 2007); (c) wide variability in the concentration profiles from sampling of blood or plasma which is possibly due to differences in the sensitivity of analytical methods and calculations of kinetic parameters, especially the terminal elimination plasma half-life (T 1/2 ) Titus 1989); (d) marked variations of plasma concentrations in relation to dosage as well as Fig. 1 The stereochemistry is important for determining the pharmacokinetics of the drug which exists as a racemic mixture of R-(-) and S(?)…”
Section: Pharmacokineticsmentioning
confidence: 99%
See 1 more Smart Citation
“…enantiomers (see Fig. 1) (Witiak et al 1981;Craig et al 1988;Titus 1989;Brocks et al 1992;Brocks and Mehvar 2003) with variable stereo-selective elimination (Iredale et al 1993;McLachlan et al 1993McLachlan et al , 1994Tett et al 1994;Ducharme et al 1995;Midha et al 1998;Munster et al 2002;Brocks and Mehvar 2003;de Oliveira et al 2007); (c) wide variability in the concentration profiles from sampling of blood or plasma which is possibly due to differences in the sensitivity of analytical methods and calculations of kinetic parameters, especially the terminal elimination plasma half-life (T 1/2 ) Titus 1989); (d) marked variations of plasma concentrations in relation to dosage as well as Fig. 1 The stereochemistry is important for determining the pharmacokinetics of the drug which exists as a racemic mixture of R-(-) and S(?)…”
Section: Pharmacokineticsmentioning
confidence: 99%
“…HCQ and CQ exist as diastereoisomers and their pharmacokinetics in humans has been investigated in several studies (Titus 1989;Brocks et al 1992;Brocks and Mehvar 2003) (Fig. 7).…”
Section: Pharmacokineticsmentioning
confidence: 99%
“…Concentrations of HCQ enantiomers in blood were measured by using a previously described high-performance liquid chromatography method (Brocks et al 1992). Briefly, after addition of chloroquine (internal standard), blood samples (0.2 mL) were alkalinized and extracted with 5 mL of diethyl ether.…”
Section: Hydroxychloroquine Assaymentioning
confidence: 99%
“…The derivatization reagent DATAN is not expensive, has great separation potential, and is a good leaving group in the collision cell, allowing the use of low collision energy and thereby increasing the selectivity of the measurement. In spite of these unique characteristics, the reagent has rarely been mentioned in the literature (12)(13)(14)(15). Other biochemically important hydroxyacids, i.e., d/l-lactate, d/l-glycerate, and d/l-3hydroxybutyrate, can also be separated enantiomerically by use of DATAN as the derivatizing reagent, without the need to change chromatographic conditions (data not shown).…”
Section: Discussionmentioning
confidence: 99%